B. Metzler seel. Sohn & Co. AG Reduces Stock Position in Molina Healthcare, Inc. (NYSE:MOH)

B. Metzler seel. Sohn & Co. AG trimmed its position in shares of Molina Healthcare, Inc. (NYSE:MOH) by 1.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,998 shares of the company’s stock after selling 61 shares during the quarter. B. Metzler seel. Sohn & Co. AG’s holdings in Molina Healthcare were worth $1,455,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Norges Bank purchased a new stake in Molina Healthcare during the fourth quarter valued at $134,675,000. Wellington Management Group LLP increased its position in shares of Molina Healthcare by 7.4% during the 4th quarter. Wellington Management Group LLP now owns 2,632,232 shares of the company’s stock valued at $766,111,000 after purchasing an additional 181,073 shares during the last quarter. Los Angeles Capital Management LLC increased its position in shares of Molina Healthcare by 166.1% during the 4th quarter. Los Angeles Capital Management LLC now owns 196,513 shares of the company’s stock valued at $57,195,000 after purchasing an additional 122,674 shares during the last quarter. Proficio Capital Partners LLC bought a new position in shares of Molina Healthcare in the 4th quarter worth approximately $26,091,000. Finally, Victory Capital Management Inc. grew its position in Molina Healthcare by 48.9% during the fourth quarter. Victory Capital Management Inc. now owns 141,184 shares of the company’s stock valued at $41,092,000 after buying an additional 46,350 shares during the period. 98.50% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Molina Healthcare

In related news, Director Steven J. Orlando sold 1,000 shares of the business’s stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total value of $301,330.00. Following the sale, the director now owns 17,375 shares in the company, valued at approximately $5,235,608.75. The trade was a 5.44 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 1.10% of the company’s stock.

Molina Healthcare Stock Performance

MOH opened at $328.27 on Thursday. The stock has a market capitalization of $17.96 billion, a price-to-earnings ratio of 16.07, a PEG ratio of 1.06 and a beta of 0.56. Molina Healthcare, Inc. has a fifty-two week low of $262.32 and a fifty-two week high of $384.35. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62. The company has a fifty day moving average of $304.95 and a 200 day moving average of $308.51.

Molina Healthcare (NYSE:MOH) last issued its earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. As a group, sell-side analysts forecast that Molina Healthcare, Inc. will post 24.4 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

MOH has been the subject of a number of research reports. StockNews.com cut shares of Molina Healthcare from a “buy” rating to a “hold” rating in a report on Thursday. Wells Fargo & Company raised Molina Healthcare from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $295.00 to $372.00 in a report on Wednesday, March 5th. Truist Financial cut their price target on Molina Healthcare from $370.00 to $340.00 and set a “buy” rating for the company in a report on Wednesday, February 19th. UBS Group decreased their price objective on Molina Healthcare from $374.00 to $325.00 and set a “neutral” rating on the stock in a research note on Friday, February 7th. Finally, Mizuho cut their price objective on Molina Healthcare from $382.00 to $376.00 and set an “outperform” rating for the company in a research note on Monday, March 3rd. Seven equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $348.75.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.